Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orthofix Medical (OFIX) EBIAT (2016 - 2025)

Orthofix Medical (OFIX) has disclosed EBIAT for 16 consecutive years, with -$2.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 92.38% year-over-year to -$2.2 million, compared with a TTM value of -$92.2 million through Dec 2025, up 26.83%, and an annual FY2025 reading of -$92.2 million, up 26.83% over the prior year.
  • EBIAT was -$2.2 million for Q4 2025 at Orthofix Medical, up from -$22.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $2.5 million in Q2 2022 and bottomed at -$60.9 million in Q1 2023.
  • Average EBIAT over 5 years is -$21.4 million, with a median of -$22.5 million recorded in 2023.
  • The sharpest move saw EBIAT soared 113.14% in 2021, then crashed 1684.01% in 2023.
  • Year by year, EBIAT stood at -$32.8 million in 2021, then surged by 78.48% to -$7.1 million in 2022, then crashed by 213.99% to -$22.2 million in 2023, then crashed by 31.44% to -$29.1 million in 2024, then soared by 92.38% to -$2.2 million in 2025.
  • Business Quant data shows EBIAT for OFIX at -$2.2 million in Q4 2025, -$22.8 million in Q3 2025, and -$14.1 million in Q2 2025.